Shares of BENITEC BIOPHAR/S (NASDAQ:BNTC) shot up 0.5% during trading on Monday . The company traded as high as $0.85 and last traded at $0.85. 2,000 shares traded hands during trading, a decline of 85% from the average session volume of 12,997 shares. The stock had previously closed at $0.85.
The company’s 50 day simple moving average is $1.59.
ILLEGAL ACTIVITY NOTICE: “BENITEC BIOPHAR/S (NASDAQ:BNTC) Shares Up 0.5%” was first published by Mayfield Recorder and is owned by of Mayfield Recorder. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://mayfieldrecorder.com/2019/06/18/benitec-biophar-s-nasdaqbntc-shares-up-0-5.html.
BENITEC BIOPHAR/S Company Profile (NASDAQ:BNTC)
Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing therapy, DNA-directed RNA interference (ddRNAi) in Australia and the United States. The company provides BB-301, a single administration ddRNAi-based gene therapy for the treatment of oculopharyngeal muscular dystrophy; BB-201, a ddRNAi-based therapy for the treatment of wet age-related macular degeneration; and BB-101 and BB-103 ddRNAi-based therapies for the treatment of human hepatitis B.
Featured Article: What is a CD ladder?
Receive News & Ratings for BENITEC BIOPHAR/S Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BENITEC BIOPHAR/S and related companies with MarketBeat.com’s FREE daily email newsletter.